A 12-week trial of a drug for essential tremor has found sustained results. The trial's outcome has reportedly been well-received, although some outlets are discussing other neurological treatments and research, making it unclear if the essential tremor drug's results are the primary focus of current attention. The drug's success may be part of a larger trend of promising developments in neurology research.